Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESDr. Konstantin Kousoulas, World's Most Eminent Virologist Is Named VP of Scientific...

Dr. Konstantin Kousoulas, World’s Most Eminent Virologist Is Named VP of Scientific Affairs at Rational Vaccines

February 26, 2021

Dr. Konstantin Kousoulas

Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus.

“Dr. Kousoulas is one of the world’s most eminent virologists. His work in the field of HSV gives hopes to the millions of patients who are in desperate need of a better standard of care and to all of us who work to defeat this heinous virus,” said Rational Vaccines CEO Agustin Fernandez. “No one understands this virus better than Gus. His addition to the team brings us one step closer to our goal of eradicating the Herpes pandemic.”

Dr. Konstantin Kousoulas is a professor of virology and biotechnology in the Louisiana State University Department of Pathobiological Sciences and director of the Division of Biotechnology and Molecular Medicine (BioMMED).

Dr. Konstantin Kousoulas research focuses primarily on the molecular biology and the immunopathogenesis of human herpes viruses. He has extensively utilized herpes simplex viral vectors for vaccine development and cancer treatment. He has also constructed and patented herpes simplex viruses that have been shown to be highly effective as preventative and therapeutic vaccines for herpes genital and ocular infections, as well as potent adjuvants for cancer immunotherapy, approaches in animal models.

Kousoulas’ work has been published in a variety of scientific publications including the Journals of Veterinary Microbiology and Journal of Virology as well as featured by news outlets around the globe. He received his Master’s and doctorate degrees from Pennsylvania State University in Biophysics and Molecular Cell Biology, respectively. Kousoulas received postdoctoral training under Dr. Bernard Roizman at the University of Chicago and with Dr. Lenore Pereira at the University of California at San Francisco.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy